nodes	percent_of_prediction	percent_of_DWPC	metapath
Etidronic acid—ATP6V1A—mammary gland—breast cancer	0.0182	0.086	CbGeAlD
Etidronic acid—ATP6V1A—nipple—breast cancer	0.0151	0.0711	CbGeAlD
Etidronic acid—PTPRS—adipose tissue—breast cancer	0.0142	0.0671	CbGeAlD
Etidronic acid—PTPRS—female reproductive system—breast cancer	0.0131	0.0617	CbGeAlD
Etidronic acid—PTPRS—adrenal gland—breast cancer	0.0127	0.0602	CbGeAlD
Etidronic acid—ATP6V1A—embryo—breast cancer	0.0124	0.0587	CbGeAlD
Etidronic acid—PTPRS—bone marrow—breast cancer	0.0123	0.0582	CbGeAlD
Etidronic acid—PTPRS—female gonad—breast cancer	0.0119	0.0561	CbGeAlD
Etidronic acid—PTPRS—endocrine gland—breast cancer	0.0111	0.0522	CbGeAlD
Etidronic acid—ATP6V1A—skin of body—breast cancer	0.00964	0.0455	CbGeAlD
Etidronic acid—ATP6V1A—endometrium—breast cancer	0.00909	0.0429	CbGeAlD
Etidronic acid—ATP6V1A—uterus—breast cancer	0.00838	0.0396	CbGeAlD
Etidronic acid—ATP6V1A—pituitary gland—breast cancer	0.00823	0.0389	CbGeAlD
Etidronic acid—ATP6V1A—adipose tissue—breast cancer	0.00819	0.0387	CbGeAlD
Etidronic acid—PTPRS—lymph node—breast cancer	0.00764	0.0361	CbGeAlD
Etidronic acid—ATP6V1A—female reproductive system—breast cancer	0.00753	0.0356	CbGeAlD
Etidronic acid—ATP6V1A—adrenal gland—breast cancer	0.00735	0.0347	CbGeAlD
Etidronic acid—ATP6V1A—bone marrow—breast cancer	0.00711	0.0336	CbGeAlD
Etidronic acid—ATP6V1A—female gonad—breast cancer	0.00685	0.0324	CbGeAlD
Etidronic acid—ATP6V1A—endocrine gland—breast cancer	0.00637	0.0301	CbGeAlD
Etidronic acid—ATP6V1A—lymph node—breast cancer	0.00441	0.0208	CbGeAlD
Etidronic acid—Zoledronate—ABCC1—breast cancer	0.00396	0.569	CrCbGaD
Etidronic acid—Risedronate—PTGS2—breast cancer	0.00159	0.228	CrCbGaD
Etidronic acid—Clodronate—PTGS2—breast cancer	0.00141	0.203	CrCbGaD
Etidronic acid—ATP6V1A—Signaling Pathways—LGR6—breast cancer	0.000563	0.00281	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CCDC88C—breast cancer	0.000563	0.00281	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—KRAS—breast cancer	0.000551	0.00275	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000551	0.00275	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HPSE—breast cancer	0.000546	0.00273	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—LDHB—breast cancer	0.000546	0.00273	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SFRP2—breast cancer	0.000546	0.00273	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—RPL31—breast cancer	0.000546	0.00273	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SFRP1—breast cancer	0.000537	0.00268	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—GPER1—breast cancer	0.000537	0.00268	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000525	0.00262	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—VCP—breast cancer	0.000518	0.00259	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HMMR—breast cancer	0.000518	0.00259	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ABCC1—breast cancer	0.000518	0.00259	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NMBR—breast cancer	0.000515	0.00257	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—RPS4X—breast cancer	0.000509	0.00254	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—TGFBI—breast cancer	0.000509	0.00254	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000507	0.00253	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—PIK3CA—breast cancer	0.000506	0.00253	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ELL—breast cancer	0.000487	0.00243	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PTGER1—breast cancer	0.000478	0.00239	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HEYL—breast cancer	0.000478	0.00239	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CUL5—breast cancer	0.000478	0.00239	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—HRAS—breast cancer	0.000468	0.00234	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000464	0.00232	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HEY2—breast cancer	0.000456	0.00228	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—PLG—breast cancer	0.000452	0.00226	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—RPS6KB2—breast cancer	0.00045	0.00225	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—RSPO3—breast cancer	0.00045	0.00225	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—IL6—breast cancer	0.000448	0.00224	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—IDH1—breast cancer	0.000445	0.00222	CbGpPWpGaD
Etidronic acid—Angioedema—Paclitaxel—breast cancer	0.000444	0.000765	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.000443	0.000763	CcSEcCtD
Etidronic acid—Vomiting—Tamoxifen—breast cancer	0.000438	0.000755	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—WWOX—breast cancer	0.000438	0.00219	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—WNT10B—breast cancer	0.000438	0.00219	CbGpPWpGaD
Etidronic acid—Paraesthesia—Irinotecan—breast cancer	0.000437	0.000752	CcSEcCtD
Etidronic acid—Paraesthesia—Mitoxantrone—breast cancer	0.000437	0.000752	CcSEcCtD
Etidronic acid—Leukopenia—Paclitaxel—breast cancer	0.000435	0.000749	CcSEcCtD
Etidronic acid—Rash—Tamoxifen—breast cancer	0.000435	0.000748	CcSEcCtD
Etidronic acid—Hypersensitivity—Vinorelbine—breast cancer	0.000435	0.000748	CcSEcCtD
Etidronic acid—Dermatitis—Tamoxifen—breast cancer	0.000434	0.000748	CcSEcCtD
Etidronic acid—Erythema multiforme—Capecitabine—breast cancer	0.000433	0.000746	CcSEcCtD
Etidronic acid—Headache—Tamoxifen—breast cancer	0.000432	0.000744	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000432	0.000743	CcSEcCtD
Etidronic acid—Vomiting—Melphalan—breast cancer	0.000429	0.000739	CcSEcCtD
Etidronic acid—Dyspepsia—Irinotecan—breast cancer	0.000428	0.000737	CcSEcCtD
Etidronic acid—Dyspepsia—Mitoxantrone—breast cancer	0.000428	0.000737	CcSEcCtD
Etidronic acid—Osteoarthritis—Doxorubicin—breast cancer	0.000427	0.000735	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PDE2A—breast cancer	0.000426	0.00213	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCL3—breast cancer	0.000426	0.00213	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CCL27—breast cancer	0.000426	0.00213	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—INHBB—breast cancer	0.000426	0.00213	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—TLE3—breast cancer	0.000426	0.00213	CbGpPWpGaD
Etidronic acid—Asthma—Methotrexate—breast cancer	0.000426	0.000734	CcSEcCtD
Etidronic acid—Rash—Melphalan—breast cancer	0.000426	0.000733	CcSEcCtD
Etidronic acid—Paraesthesia—Gemcitabine—breast cancer	0.000426	0.000732	CcSEcCtD
Etidronic acid—Dermatitis—Melphalan—breast cancer	0.000425	0.000732	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000425	0.000731	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—HEY1—breast cancer	0.000422	0.00211	CbGpPWpGaD
Etidronic acid—Nausea—Vinblastine—breast cancer	0.000422	0.000726	CcSEcCtD
Etidronic acid—Vomiting—Goserelin—breast cancer	0.000419	0.000721	CcSEcCtD
Etidronic acid—Paraesthesia—Fluorouracil—breast cancer	0.000418	0.00072	CcSEcCtD
Etidronic acid—Alopecia—Docetaxel—breast cancer	0.000418	0.00072	CcSEcCtD
Etidronic acid—Pruritus—Vinorelbine—breast cancer	0.000417	0.000718	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000417	0.00208	CbGpPWpGaD
Etidronic acid—Constipation—Mitoxantrone—breast cancer	0.000416	0.000716	CcSEcCtD
Etidronic acid—Constipation—Irinotecan—breast cancer	0.000416	0.000716	CcSEcCtD
Etidronic acid—Rash—Goserelin—breast cancer	0.000415	0.000715	CcSEcCtD
Etidronic acid—Hypersensitivity—Thiotepa—breast cancer	0.000415	0.000714	CcSEcCtD
Etidronic acid—Dermatitis—Goserelin—breast cancer	0.000415	0.000714	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—RPL23A—breast cancer	0.000414	0.00207	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—DLL1—breast cancer	0.000414	0.00207	CbGpPWpGaD
Etidronic acid—Arthralgia—Paclitaxel—breast cancer	0.000414	0.000712	CcSEcCtD
Etidronic acid—Headache—Goserelin—breast cancer	0.000413	0.00071	CcSEcCtD
Etidronic acid—Erythema—Docetaxel—breast cancer	0.000412	0.000709	CcSEcCtD
Etidronic acid—Dyspepsia—Fluorouracil—breast cancer	0.00041	0.000706	CcSEcCtD
Etidronic acid—Nausea—Tamoxifen—breast cancer	0.00041	0.000705	CcSEcCtD
Etidronic acid—Discomfort—Paclitaxel—breast cancer	0.000409	0.000704	CcSEcCtD
Etidronic acid—Gastritis—Epirubicin—breast cancer	0.000408	0.000703	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—DLL4—breast cancer	0.000407	0.00203	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—BMPR2—breast cancer	0.000407	0.00203	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HIST1H2BC—breast cancer	0.000406	0.00203	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MAP2K7—breast cancer	0.000406	0.00203	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HIST1H2BK—breast cancer	0.000406	0.00203	CbGpPWpGaD
Etidronic acid—Constipation—Gemcitabine—breast cancer	0.000405	0.000698	CcSEcCtD
Etidronic acid—Alopecia—Capecitabine—breast cancer	0.000405	0.000697	CcSEcCtD
Etidronic acid—Pancytopenia—Methotrexate—breast cancer	0.000405	0.000697	CcSEcCtD
Etidronic acid—Diarrhoea—Vinorelbine—breast cancer	0.000404	0.000695	CcSEcCtD
Etidronic acid—Nausea—Melphalan—breast cancer	0.000401	0.00069	CcSEcCtD
Etidronic acid—Feeling abnormal—Mitoxantrone—breast cancer	0.000401	0.00069	CcSEcCtD
Etidronic acid—Feeling abnormal—Irinotecan—breast cancer	0.000401	0.00069	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000401	0.002	CbGpPWpGaD
Etidronic acid—Confusional state—Paclitaxel—breast cancer	0.0004	0.000689	CcSEcCtD
Etidronic acid—Erythema—Capecitabine—breast cancer	0.000399	0.000687	CcSEcCtD
Etidronic acid—Asthma—Epirubicin—breast cancer	0.000399	0.000687	CcSEcCtD
Etidronic acid—Pruritus—Thiotepa—breast cancer	0.000399	0.000686	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000398	0.000685	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Irinotecan—breast cancer	0.000398	0.000685	CcSEcCtD
Etidronic acid—Muscle spasms—Docetaxel—breast cancer	0.000396	0.000682	CcSEcCtD
Etidronic acid—Infection—Paclitaxel—breast cancer	0.000394	0.000678	CcSEcCtD
Etidronic acid—Flatulence—Capecitabine—breast cancer	0.000393	0.000677	CcSEcCtD
Etidronic acid—Nausea—Goserelin—breast cancer	0.000391	0.000673	CcSEcCtD
Etidronic acid—Feeling abnormal—Gemcitabine—breast cancer	0.000391	0.000672	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CDH5—breast cancer	0.00039	0.00195	CbGpPWpGaD
Etidronic acid—Urticaria—Mitoxantrone—breast cancer	0.000387	0.000665	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—RPS8—breast cancer	0.000386	0.00193	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—RPS7—breast cancer	0.000386	0.00193	CbGpPWpGaD
Etidronic acid—Diarrhoea—Thiotepa—breast cancer	0.000385	0.000663	CcSEcCtD
Etidronic acid—Abdominal pain—Irinotecan—breast cancer	0.000385	0.000662	CcSEcCtD
Etidronic acid—Abdominal pain—Mitoxantrone—breast cancer	0.000385	0.000662	CcSEcCtD
Etidronic acid—Feeling abnormal—Fluorouracil—breast cancer	0.000384	0.000661	CcSEcCtD
Etidronic acid—Muscle spasms—Capecitabine—breast cancer	0.000384	0.00066	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—DKK1—breast cancer	0.000383	0.00191	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SFRP2—breast cancer	0.000383	0.00191	CbGpPWpGaD
Etidronic acid—Anaemia—Docetaxel—breast cancer	0.000381	0.000656	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—ALDOA—breast cancer	0.00038	0.0019	CbGpPWpGaD
Etidronic acid—Pancytopenia—Epirubicin—breast cancer	0.000379	0.000652	CcSEcCtD
Etidronic acid—Gastritis—Doxorubicin—breast cancer	0.000378	0.00065	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000377	0.000649	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PRLR—breast cancer	0.000375	0.00188	CbGpPWpGaD
Etidronic acid—Vomiting—Vinorelbine—breast cancer	0.000375	0.000646	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—JAG2—breast cancer	0.000374	0.00187	CbGpPWpGaD
Etidronic acid—Rash—Vinorelbine—breast cancer	0.000372	0.00064	CcSEcCtD
Etidronic acid—Dermatitis—Vinorelbine—breast cancer	0.000372	0.00064	CcSEcCtD
Etidronic acid—Urticaria—Fluorouracil—breast cancer	0.00037	0.000637	CcSEcCtD
Etidronic acid—Headache—Vinorelbine—breast cancer	0.00037	0.000636	CcSEcCtD
Etidronic acid—Asthma—Doxorubicin—breast cancer	0.000369	0.000635	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—WNT1—breast cancer	0.000369	0.00184	CbGpPWpGaD
Etidronic acid—Leukopenia—Docetaxel—breast cancer	0.000369	0.000635	CcSEcCtD
Etidronic acid—Anaemia—Capecitabine—breast cancer	0.000369	0.000635	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—SLC2A2—breast cancer	0.000366	0.00183	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—GLI2—breast cancer	0.000363	0.00181	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—VCP—breast cancer	0.000363	0.00181	CbGpPWpGaD
Etidronic acid—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000362	0.000622	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—MTR—breast cancer	0.000359	0.00179	CbGpPWpGaD
Etidronic acid—Hypersensitivity—Mitoxantrone—breast cancer	0.000358	0.000617	CcSEcCtD
Etidronic acid—Hypersensitivity—Irinotecan—breast cancer	0.000358	0.000617	CcSEcCtD
Etidronic acid—Vomiting—Thiotepa—breast cancer	0.000358	0.000617	CcSEcCtD
Etidronic acid—Leukopenia—Capecitabine—breast cancer	0.000357	0.000615	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—LEPR—breast cancer	0.000357	0.00178	CbGpPWpGaD
Etidronic acid—Paraesthesia—Paclitaxel—breast cancer	0.000356	0.000613	CcSEcCtD
Etidronic acid—Rash—Thiotepa—breast cancer	0.000355	0.000611	CcSEcCtD
Etidronic acid—Dermatitis—Thiotepa—breast cancer	0.000355	0.000611	CcSEcCtD
Etidronic acid—Agranulocytosis—Methotrexate—breast cancer	0.000355	0.00061	CcSEcCtD
Etidronic acid—Headache—Thiotepa—breast cancer	0.000353	0.000607	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000353	0.000607	CcSEcCtD
Etidronic acid—Arthralgia—Docetaxel—breast cancer	0.000351	0.000604	CcSEcCtD
Etidronic acid—Pancytopenia—Doxorubicin—breast cancer	0.000351	0.000603	CcSEcCtD
Etidronic acid—Nausea—Vinorelbine—breast cancer	0.00035	0.000603	CcSEcCtD
Etidronic acid—Dyspepsia—Paclitaxel—breast cancer	0.000349	0.000601	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Epirubicin—breast cancer	0.000349	0.0006	CcSEcCtD
Etidronic acid—Hypersensitivity—Fluorouracil—breast cancer	0.000343	0.000591	CcSEcCtD
Etidronic acid—Arthralgia—Capecitabine—breast cancer	0.00034	0.000585	CcSEcCtD
Etidronic acid—Constipation—Paclitaxel—breast cancer	0.000339	0.000584	CcSEcCtD
Etidronic acid—Confusional state—Docetaxel—breast cancer	0.000339	0.000584	CcSEcCtD
Etidronic acid—Discomfort—Capecitabine—breast cancer	0.000336	0.000578	CcSEcCtD
Etidronic acid—Pruritus—Gemcitabine—breast cancer	0.000335	0.000577	CcSEcCtD
Etidronic acid—Nausea—Thiotepa—breast cancer	0.000335	0.000576	CcSEcCtD
Etidronic acid—Infection—Docetaxel—breast cancer	0.000334	0.000575	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—HSPA1B—breast cancer	0.000334	0.00167	CbGpPWpGaD
Etidronic acid—Diarrhoea—Mitoxantrone—breast cancer	0.000333	0.000573	CcSEcCtD
Etidronic acid—Diarrhoea—Irinotecan—breast cancer	0.000333	0.000573	CcSEcCtD
Etidronic acid—Agranulocytosis—Epirubicin—breast cancer	0.000332	0.000571	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—ARHGDIA—breast cancer	0.000332	0.00166	CbGpPWpGaD
Etidronic acid—Pruritus—Fluorouracil—breast cancer	0.00033	0.000567	CcSEcCtD
Etidronic acid—Confusional state—Capecitabine—breast cancer	0.000328	0.000565	CcSEcCtD
Etidronic acid—Feeling abnormal—Paclitaxel—breast cancer	0.000327	0.000563	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000326	0.000562	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Paclitaxel—breast cancer	0.000324	0.000558	CcSEcCtD
Etidronic acid—Diarrhoea—Gemcitabine—breast cancer	0.000324	0.000558	CcSEcCtD
Etidronic acid—Infection—Capecitabine—breast cancer	0.000324	0.000557	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—FST—breast cancer	0.000323	0.00161	CbGpPWpGaD
Etidronic acid—Erythema multiforme—Methotrexate—breast cancer	0.000323	0.000555	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Doxorubicin—breast cancer	0.000323	0.000555	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—ENO1—breast cancer	0.00032	0.0016	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HEY2—breast cancer	0.000319	0.00159	CbGpPWpGaD
Etidronic acid—Diarrhoea—Fluorouracil—breast cancer	0.000319	0.000549	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—RPS6KB2—breast cancer	0.000315	0.00158	CbGpPWpGaD
Etidronic acid—Urticaria—Paclitaxel—breast cancer	0.000315	0.000543	CcSEcCtD
Etidronic acid—Abdominal pain—Paclitaxel—breast cancer	0.000314	0.00054	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—RGS2—breast cancer	0.000312	0.00156	CbGpPWpGaD
Etidronic acid—Vomiting—Mitoxantrone—breast cancer	0.000309	0.000532	CcSEcCtD
Etidronic acid—Vomiting—Irinotecan—breast cancer	0.000309	0.000532	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CCL20—breast cancer	0.000308	0.00154	CbGpPWpGaD
Etidronic acid—Agranulocytosis—Doxorubicin—breast cancer	0.000307	0.000529	CcSEcCtD
Etidronic acid—Rash—Mitoxantrone—breast cancer	0.000307	0.000528	CcSEcCtD
Etidronic acid—Rash—Irinotecan—breast cancer	0.000307	0.000528	CcSEcCtD
Etidronic acid—Dermatitis—Mitoxantrone—breast cancer	0.000307	0.000527	CcSEcCtD
Etidronic acid—Dermatitis—Irinotecan—breast cancer	0.000307	0.000527	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000306	0.000527	CcSEcCtD
Etidronic acid—Headache—Irinotecan—breast cancer	0.000305	0.000525	CcSEcCtD
Etidronic acid—Headache—Mitoxantrone—breast cancer	0.000305	0.000525	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—FGF3—breast cancer	0.000303	0.00151	CbGpPWpGaD
Etidronic acid—Paraesthesia—Docetaxel—breast cancer	0.000302	0.00052	CcSEcCtD
Etidronic acid—Erythema multiforme—Epirubicin—breast cancer	0.000302	0.00052	CcSEcCtD
Etidronic acid—Alopecia—Methotrexate—breast cancer	0.000302	0.000519	CcSEcCtD
Etidronic acid—Vomiting—Gemcitabine—breast cancer	0.000301	0.000519	CcSEcCtD
Etidronic acid—Rash—Gemcitabine—breast cancer	0.000299	0.000514	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—JAG1—breast cancer	0.000299	0.00149	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—FASN—breast cancer	0.000299	0.00149	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—LPAR1—breast cancer	0.000299	0.00149	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TLE3—breast cancer	0.000299	0.00149	CbGpPWpGaD
Etidronic acid—Dermatitis—Gemcitabine—breast cancer	0.000299	0.000514	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—PARP1—breast cancer	0.000297	0.00149	CbGpPWpGaD
Etidronic acid—Erythema—Methotrexate—breast cancer	0.000297	0.000511	CcSEcCtD
Etidronic acid—Headache—Gemcitabine—breast cancer	0.000297	0.000511	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000297	0.000511	CcSEcCtD
Etidronic acid—Vomiting—Fluorouracil—breast cancer	0.000296	0.00051	CcSEcCtD
Etidronic acid—Dyspepsia—Docetaxel—breast cancer	0.000296	0.00051	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—HEY1—breast cancer	0.000296	0.00148	CbGpPWpGaD
Etidronic acid—Rash—Fluorouracil—breast cancer	0.000294	0.000506	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—CALCA—breast cancer	0.000294	0.00147	CbGpPWpGaD
Etidronic acid—Dermatitis—Fluorouracil—breast cancer	0.000294	0.000505	CcSEcCtD
Etidronic acid—Paraesthesia—Capecitabine—breast cancer	0.000292	0.000503	CcSEcCtD
Etidronic acid—Hypersensitivity—Paclitaxel—breast cancer	0.000292	0.000503	CcSEcCtD
Etidronic acid—Headache—Fluorouracil—breast cancer	0.000292	0.000502	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—RPS6—breast cancer	0.00029	0.00145	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—DLL1—breast cancer	0.00029	0.00145	CbGpPWpGaD
Etidronic acid—Nausea—Mitoxantrone—breast cancer	0.000289	0.000497	CcSEcCtD
Etidronic acid—Nausea—Irinotecan—breast cancer	0.000289	0.000497	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—FGF4—breast cancer	0.000288	0.00144	CbGpPWpGaD
Etidronic acid—Constipation—Docetaxel—breast cancer	0.000288	0.000495	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—CXCR4—breast cancer	0.000287	0.00143	CbGpPWpGaD
Etidronic acid—Dyspepsia—Capecitabine—breast cancer	0.000287	0.000493	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—HIST1H2BK—breast cancer	0.000285	0.00142	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HIST1H2BC—breast cancer	0.000285	0.00142	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SLC2A1—breast cancer	0.000284	0.00142	CbGpPWpGaD
Etidronic acid—Alopecia—Epirubicin—breast cancer	0.000282	0.000486	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PDE4D—breast cancer	0.000282	0.00141	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—GRB7—breast cancer	0.000282	0.00141	CbGpPWpGaD
Etidronic acid—Nausea—Gemcitabine—breast cancer	0.000282	0.000485	CcSEcCtD
Etidronic acid—Pruritus—Paclitaxel—breast cancer	0.000281	0.000483	CcSEcCtD
Etidronic acid—Erythema multiforme—Doxorubicin—breast cancer	0.000279	0.000481	CcSEcCtD
Etidronic acid—Constipation—Capecitabine—breast cancer	0.000278	0.000479	CcSEcCtD
Etidronic acid—Erythema—Epirubicin—breast cancer	0.000278	0.000478	CcSEcCtD
Etidronic acid—Feeling abnormal—Docetaxel—breast cancer	0.000277	0.000477	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—TAB2—breast cancer	0.000277	0.00138	CbGpPWpGaD
Etidronic acid—Nausea—Fluorouracil—breast cancer	0.000277	0.000476	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—TCF7L2—breast cancer	0.000277	0.00138	CbGpPWpGaD
Etidronic acid—Gastrointestinal pain—Docetaxel—breast cancer	0.000275	0.000473	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CNR2—breast cancer	0.000275	0.00137	CbGpPWpGaD
Etidronic acid—Anaemia—Methotrexate—breast cancer	0.000275	0.000472	CcSEcCtD
Etidronic acid—Flatulence—Epirubicin—breast cancer	0.000274	0.000471	CcSEcCtD
Etidronic acid—Diarrhoea—Paclitaxel—breast cancer	0.000272	0.000467	CcSEcCtD
Etidronic acid—Feeling abnormal—Capecitabine—breast cancer	0.000268	0.000462	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—DKK1—breast cancer	0.000268	0.00134	CbGpPWpGaD
Etidronic acid—Muscle spasms—Epirubicin—breast cancer	0.000267	0.00046	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—HSP90AA1—breast cancer	0.000267	0.00133	CbGpPWpGaD
Etidronic acid—Gastrointestinal pain—Capecitabine—breast cancer	0.000266	0.000458	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—VEGFC—breast cancer	0.000266	0.00133	CbGpPWpGaD
Etidronic acid—Abdominal pain—Docetaxel—breast cancer	0.000266	0.000458	CcSEcCtD
Etidronic acid—Leukopenia—Methotrexate—breast cancer	0.000266	0.000458	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—JAG2—breast cancer	0.000262	0.00131	CbGpPWpGaD
Etidronic acid—Alopecia—Doxorubicin—breast cancer	0.000261	0.000449	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—PRL—breast cancer	0.000259	0.0013	CbGpPWpGaD
Etidronic acid—Urticaria—Capecitabine—breast cancer	0.000259	0.000445	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—WNT1—breast cancer	0.000258	0.00129	CbGpPWpGaD
Etidronic acid—Abdominal pain—Capecitabine—breast cancer	0.000257	0.000443	CcSEcCtD
Etidronic acid—Erythema—Doxorubicin—breast cancer	0.000257	0.000443	CcSEcCtD
Etidronic acid—Anaemia—Epirubicin—breast cancer	0.000257	0.000442	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—ADAM10—breast cancer	0.000256	0.00128	CbGpPWpGaD
Etidronic acid—Flatulence—Doxorubicin—breast cancer	0.000253	0.000436	CcSEcCtD
Etidronic acid—Arthralgia—Methotrexate—breast cancer	0.000253	0.000435	CcSEcCtD
Etidronic acid—Vomiting—Paclitaxel—breast cancer	0.000252	0.000434	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—ALB—breast cancer	0.000251	0.00125	CbGpPWpGaD
Etidronic acid—Rash—Paclitaxel—breast cancer	0.00025	0.000431	CcSEcCtD
Etidronic acid—Dermatitis—Paclitaxel—breast cancer	0.00025	0.00043	CcSEcCtD
Etidronic acid—Discomfort—Methotrexate—breast cancer	0.00025	0.00043	CcSEcCtD
Etidronic acid—Leukopenia—Epirubicin—breast cancer	0.000249	0.000428	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—FGF10—breast cancer	0.000249	0.00124	CbGpPWpGaD
Etidronic acid—Headache—Paclitaxel—breast cancer	0.000249	0.000428	CcSEcCtD
Etidronic acid—Hypersensitivity—Docetaxel—breast cancer	0.000248	0.000426	CcSEcCtD
Etidronic acid—Muscle spasms—Doxorubicin—breast cancer	0.000247	0.000426	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—NOTCH4—breast cancer	0.000245	0.00122	CbGpPWpGaD
Etidronic acid—Confusional state—Methotrexate—breast cancer	0.000244	0.000421	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—GZMB—breast cancer	0.000243	0.00122	CbGpPWpGaD
Etidronic acid—Infection—Methotrexate—breast cancer	0.000241	0.000414	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—PDGFA—breast cancer	0.00024	0.0012	CbGpPWpGaD
Etidronic acid—Hypersensitivity—Capecitabine—breast cancer	0.00024	0.000413	CcSEcCtD
Etidronic acid—Pruritus—Docetaxel—breast cancer	0.000238	0.00041	CcSEcCtD
Etidronic acid—Anaemia—Doxorubicin—breast cancer	0.000238	0.000409	CcSEcCtD
Etidronic acid—Arthralgia—Epirubicin—breast cancer	0.000237	0.000407	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—TGFBR2—breast cancer	0.000237	0.00118	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—AGTR2—breast cancer	0.000236	0.00118	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCL2—breast cancer	0.000236	0.00118	CbGpPWpGaD
Etidronic acid—Nausea—Paclitaxel—breast cancer	0.000236	0.000406	CcSEcCtD
Etidronic acid—Discomfort—Epirubicin—breast cancer	0.000234	0.000402	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PTHLH—breast cancer	0.000234	0.00117	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—BMP2—breast cancer	0.000234	0.00117	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ITPR1—breast cancer	0.000233	0.00116	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ERBB4—breast cancer	0.000231	0.00116	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—STAT5A—breast cancer	0.000231	0.00116	CbGpPWpGaD
Etidronic acid—Pruritus—Capecitabine—breast cancer	0.00023	0.000397	CcSEcCtD
Etidronic acid—Leukopenia—Doxorubicin—breast cancer	0.00023	0.000396	CcSEcCtD
Etidronic acid—Diarrhoea—Docetaxel—breast cancer	0.00023	0.000396	CcSEcCtD
Etidronic acid—Confusional state—Epirubicin—breast cancer	0.000229	0.000394	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—RAF1—breast cancer	0.000227	0.00113	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EDNRB—breast cancer	0.000226	0.00113	CbGpPWpGaD
Etidronic acid—Infection—Epirubicin—breast cancer	0.000225	0.000388	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PGR—breast cancer	0.000224	0.00112	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SMAD4—breast cancer	0.000224	0.00112	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—THBS1—breast cancer	0.000223	0.00111	CbGpPWpGaD
Etidronic acid—Diarrhoea—Capecitabine—breast cancer	0.000223	0.000383	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000221	0.00038	CcSEcCtD
Etidronic acid—Arthralgia—Doxorubicin—breast cancer	0.000219	0.000377	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—HES1—breast cancer	0.000219	0.00109	CbGpPWpGaD
Etidronic acid—Paraesthesia—Methotrexate—breast cancer	0.000218	0.000375	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—NCOR1—breast cancer	0.000217	0.00109	CbGpPWpGaD
Etidronic acid—Discomfort—Doxorubicin—breast cancer	0.000216	0.000372	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—FGF1—breast cancer	0.000215	0.00107	CbGpPWpGaD
Etidronic acid—Vomiting—Docetaxel—breast cancer	0.000214	0.000368	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—NRG1—breast cancer	0.000213	0.00107	CbGpPWpGaD
Etidronic acid—Dyspepsia—Methotrexate—breast cancer	0.000213	0.000367	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—FLT1—breast cancer	0.000213	0.00106	CbGpPWpGaD
Etidronic acid—Rash—Docetaxel—breast cancer	0.000212	0.000365	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—H2AFX—breast cancer	0.000212	0.00106	CbGpPWpGaD
Etidronic acid—Dermatitis—Docetaxel—breast cancer	0.000212	0.000365	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—FGF3—breast cancer	0.000212	0.00106	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SQSTM1—breast cancer	0.000212	0.00106	CbGpPWpGaD
Etidronic acid—Confusional state—Doxorubicin—breast cancer	0.000212	0.000364	CcSEcCtD
Etidronic acid—Headache—Docetaxel—breast cancer	0.000211	0.000363	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—JAG1—breast cancer	0.000209	0.00104	CbGpPWpGaD
Etidronic acid—Infection—Doxorubicin—breast cancer	0.000209	0.000359	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PARP1—breast cancer	0.000208	0.00104	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NOTCH3—breast cancer	0.000208	0.00104	CbGpPWpGaD
Etidronic acid—Vomiting—Capecitabine—breast cancer	0.000207	0.000356	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000207	0.000356	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CALCA—breast cancer	0.000206	0.00103	CbGpPWpGaD
Etidronic acid—Rash—Capecitabine—breast cancer	0.000205	0.000353	CcSEcCtD
Etidronic acid—Dermatitis—Capecitabine—breast cancer	0.000205	0.000353	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—ERCC2—breast cancer	0.000204	0.00102	CbGpPWpGaD
Etidronic acid—Headache—Capecitabine—breast cancer	0.000204	0.000351	CcSEcCtD
Etidronic acid—Paraesthesia—Epirubicin—breast cancer	0.000204	0.000351	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—RPS6—breast cancer	0.000203	0.00102	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FGF4—breast cancer	0.000202	0.00101	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCR4—breast cancer	0.000201	0.001	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCL12—breast cancer	0.000201	0.001	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ERBB3—breast cancer	0.0002	0.000999	CbGpPWpGaD
Etidronic acid—Nausea—Docetaxel—breast cancer	0.0002	0.000344	CcSEcCtD
Etidronic acid—Feeling abnormal—Methotrexate—breast cancer	0.0002	0.000344	CcSEcCtD
Etidronic acid—Dyspepsia—Epirubicin—breast cancer	0.0002	0.000344	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—FGFR2—breast cancer	0.0002	0.000997	CbGpPWpGaD
Etidronic acid—Gastrointestinal pain—Methotrexate—breast cancer	0.000198	0.000341	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PAK1—breast cancer	0.000197	0.000985	CbGpPWpGaD
Etidronic acid—Constipation—Epirubicin—breast cancer	0.000194	0.000334	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—TCF7L2—breast cancer	0.000194	0.000968	CbGpPWpGaD
Etidronic acid—Nausea—Capecitabine—breast cancer	0.000193	0.000333	CcSEcCtD
Etidronic acid—Urticaria—Methotrexate—breast cancer	0.000193	0.000331	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—MTHFR—breast cancer	0.000192	0.00096	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—TERT—breast cancer	0.000192	0.000957	CbGpPWpGaD
Etidronic acid—Abdominal pain—Methotrexate—breast cancer	0.000192	0.00033	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000191	0.000329	CcSEcCtD
Etidronic acid—Paraesthesia—Doxorubicin—breast cancer	0.000188	0.000324	CcSEcCtD
Etidronic acid—Feeling abnormal—Epirubicin—breast cancer	0.000187	0.000322	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—NOTCH2—breast cancer	0.000187	0.000933	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HSP90AA1—breast cancer	0.000187	0.000933	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—FGFR1—breast cancer	0.000186	0.000929	CbGpPWpGaD
Etidronic acid—Gastrointestinal pain—Epirubicin—breast cancer	0.000186	0.000319	CcSEcCtD
Etidronic acid—Dyspepsia—Doxorubicin—breast cancer	0.000185	0.000318	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—HIF1A—breast cancer	0.000183	0.000915	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—AGTR1—breast cancer	0.000182	0.000907	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PRL—breast cancer	0.000182	0.000907	CbGpPWpGaD
Etidronic acid—Urticaria—Epirubicin—breast cancer	0.00018	0.00031	CcSEcCtD
Etidronic acid—Constipation—Doxorubicin—breast cancer	0.00018	0.000309	CcSEcCtD
Etidronic acid—Abdominal pain—Epirubicin—breast cancer	0.000179	0.000309	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—STK11—breast cancer	0.000179	0.000894	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ADAM10—breast cancer	0.000179	0.000894	CbGpPWpGaD
Etidronic acid—Hypersensitivity—Methotrexate—breast cancer	0.000179	0.000307	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—CAV1—breast cancer	0.000177	0.000885	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PLG—breast cancer	0.000177	0.000884	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FGF10—breast cancer	0.000174	0.00087	CbGpPWpGaD
Etidronic acid—Feeling abnormal—Doxorubicin—breast cancer	0.000173	0.000298	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Doxorubicin—breast cancer	0.000172	0.000295	CcSEcCtD
Etidronic acid—Pruritus—Methotrexate—breast cancer	0.000172	0.000295	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PDGFA—breast cancer	0.000168	0.00084	CbGpPWpGaD
Etidronic acid—Hypersensitivity—Epirubicin—breast cancer	0.000167	0.000288	CcSEcCtD
Etidronic acid—Urticaria—Doxorubicin—breast cancer	0.000167	0.000287	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—NOS2—breast cancer	0.000167	0.000833	CbGpPWpGaD
Etidronic acid—Abdominal pain—Doxorubicin—breast cancer	0.000166	0.000286	CcSEcCtD
Etidronic acid—Diarrhoea—Methotrexate—breast cancer	0.000166	0.000285	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—TGFBR2—breast cancer	0.000166	0.000828	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—NOTCH1—breast cancer	0.000165	0.000825	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ITPR1—breast cancer	0.000163	0.000814	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MMP3—breast cancer	0.000162	0.000809	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ERBB4—breast cancer	0.000162	0.000809	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—STAT5A—breast cancer	0.000162	0.000809	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—APC—breast cancer	0.000161	0.000806	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—KIT—breast cancer	0.000161	0.000806	CbGpPWpGaD
Etidronic acid—Pruritus—Epirubicin—breast cancer	0.000161	0.000276	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—EGF—breast cancer	0.00016	0.000797	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SMAD4—breast cancer	0.000157	0.000783	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IGF1R—breast cancer	0.000156	0.000779	CbGpPWpGaD
Etidronic acid—Diarrhoea—Epirubicin—breast cancer	0.000155	0.000267	CcSEcCtD
Etidronic acid—Hypersensitivity—Doxorubicin—breast cancer	0.000155	0.000266	CcSEcCtD
Etidronic acid—Vomiting—Methotrexate—breast cancer	0.000154	0.000265	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—HES1—breast cancer	0.000153	0.000765	CbGpPWpGaD
Etidronic acid—Rash—Methotrexate—breast cancer	0.000153	0.000263	CcSEcCtD
Etidronic acid—Dermatitis—Methotrexate—breast cancer	0.000153	0.000263	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—NCOR1—breast cancer	0.000152	0.00076	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PLA2G4A—breast cancer	0.000152	0.00076	CbGpPWpGaD
Etidronic acid—Headache—Methotrexate—breast cancer	0.000152	0.000261	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—BRAF—breast cancer	0.000152	0.000758	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CSF2—breast cancer	0.000151	0.000752	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FGF1—breast cancer	0.000151	0.000752	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NRG1—breast cancer	0.000149	0.000746	CbGpPWpGaD
Etidronic acid—Pruritus—Doxorubicin—breast cancer	0.000149	0.000256	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—H2AFX—breast cancer	0.000148	0.000741	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—AKT2—breast cancer	0.000148	0.000738	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—E2F1—breast cancer	0.000147	0.000736	CbGpPWpGaD
Etidronic acid—Vomiting—Epirubicin—breast cancer	0.000144	0.000248	CcSEcCtD
Etidronic acid—Nausea—Methotrexate—breast cancer	0.000144	0.000248	CcSEcCtD
Etidronic acid—Diarrhoea—Doxorubicin—breast cancer	0.000144	0.000247	CcSEcCtD
Etidronic acid—Rash—Epirubicin—breast cancer	0.000143	0.000246	CcSEcCtD
Etidronic acid—Dermatitis—Epirubicin—breast cancer	0.000143	0.000246	CcSEcCtD
Etidronic acid—Headache—Epirubicin—breast cancer	0.000142	0.000245	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—PIK3CD—breast cancer	0.000142	0.000709	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SPP1—breast cancer	0.000142	0.000707	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SERPINE1—breast cancer	0.00014	0.000701	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ERBB3—breast cancer	0.00014	0.000699	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FGFR2—breast cancer	0.00014	0.000698	CbGpPWpGaD
Etidronic acid—Nausea—Epirubicin—breast cancer	0.000135	0.000232	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—TERT—breast cancer	0.000134	0.00067	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—NOS3—breast cancer	0.000134	0.000669	CbGpPWpGaD
Etidronic acid—Vomiting—Doxorubicin—breast cancer	0.000133	0.00023	CcSEcCtD
Etidronic acid—Rash—Doxorubicin—breast cancer	0.000132	0.000228	CcSEcCtD
Etidronic acid—Dermatitis—Doxorubicin—breast cancer	0.000132	0.000228	CcSEcCtD
Etidronic acid—Headache—Doxorubicin—breast cancer	0.000132	0.000226	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—FGFR1—breast cancer	0.00013	0.000651	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HIF1A—breast cancer	0.000128	0.000641	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MDM2—breast cancer	0.000127	0.000635	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—RAF1—breast cancer	0.000127	0.000633	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ERBB2—breast cancer	0.000125	0.000626	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—LEP—breast cancer	0.000125	0.000626	CbGpPWpGaD
Etidronic acid—Nausea—Doxorubicin—breast cancer	0.000125	0.000215	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CAV1—breast cancer	0.000124	0.00062	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PIK3CB—breast cancer	0.000124	0.000618	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MTOR—breast cancer	0.000124	0.000618	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CD4—breast cancer	0.000123	0.000617	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—KDR—breast cancer	0.000123	0.000613	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PTGS2—breast cancer	0.000123	0.000612	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ESR1—breast cancer	0.00012	0.000597	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FN1—breast cancer	0.000118	0.00059	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NFKBIA—breast cancer	0.000117	0.000583	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CDKN1B—breast cancer	0.000116	0.00058	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NOTCH1—breast cancer	0.000116	0.000577	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—APC—breast cancer	0.000113	0.000565	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CG—breast cancer	0.000113	0.000565	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—KIT—breast cancer	0.000113	0.000565	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EGF—breast cancer	0.000112	0.000558	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CTNNB1—breast cancer	0.00011	0.000548	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CDKN1A—breast cancer	0.000107	0.000535	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PTEN—breast cancer	0.000107	0.000534	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—BRAF—breast cancer	0.000106	0.000531	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IGF1—breast cancer	0.000104	0.000517	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—AKT2—breast cancer	0.000103	0.000517	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CD—breast cancer	9.94e-05	0.000496	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SRC—breast cancer	9.91e-05	0.000495	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SERPINE1—breast cancer	9.83e-05	0.000491	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—STAT3—breast cancer	9.56e-05	0.000478	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NOS3—breast cancer	9.39e-05	0.000469	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MAPK3—breast cancer	9.13e-05	0.000456	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MDM2—breast cancer	8.91e-05	0.000445	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MYC—breast cancer	8.88e-05	0.000444	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—RAF1—breast cancer	8.87e-05	0.000443	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—TGFB1—breast cancer	8.86e-05	0.000443	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—RELA—breast cancer	8.84e-05	0.000441	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ERBB2—breast cancer	8.78e-05	0.000438	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—EGFR—breast cancer	8.69e-05	0.000434	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CB—breast cancer	8.66e-05	0.000433	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MTOR—breast cancer	8.66e-05	0.000433	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCL8—breast cancer	8.33e-05	0.000416	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—KRAS—breast cancer	8.21e-05	0.00041	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CDKN1B—breast cancer	8.13e-05	0.000406	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CASP3—breast cancer	7.97e-05	0.000398	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IL2—breast cancer	7.96e-05	0.000397	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CCND1—breast cancer	7.76e-05	0.000387	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—JUN—breast cancer	7.74e-05	0.000387	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CTNNB1—breast cancer	7.68e-05	0.000384	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PIK3CA—breast cancer	7.54e-05	0.000377	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MMP9—breast cancer	7.53e-05	0.000376	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CDKN1A—breast cancer	7.5e-05	0.000375	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PTEN—breast cancer	7.49e-05	0.000374	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MAPK8—breast cancer	7.32e-05	0.000366	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HRAS—breast cancer	6.98e-05	0.000348	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SRC—breast cancer	6.94e-05	0.000347	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—VEGFA—breast cancer	6.76e-05	0.000338	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—STAT3—breast cancer	6.7e-05	0.000334	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—IL6—breast cancer	6.68e-05	0.000334	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MAPK3—breast cancer	6.4e-05	0.000319	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MYC—breast cancer	6.22e-05	0.000311	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TGFB1—breast cancer	6.21e-05	0.00031	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—AKT1—breast cancer	6.16e-05	0.000308	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EGFR—breast cancer	6.09e-05	0.000304	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—KRAS—breast cancer	5.75e-05	0.000287	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CA—breast cancer	5.28e-05	0.000264	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TP53—breast cancer	5.11e-05	0.000255	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HRAS—breast cancer	4.89e-05	0.000244	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IL6—breast cancer	4.68e-05	0.000234	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—AKT1—breast cancer	4.31e-05	0.000215	CbGpPWpGaD
